4Brennan DC. cytomegalovirus in renal transplantation. Journal of the American Society of Nephrology. 2001. 12 (4) : 848.
5Kano Y. Shiohara T. Current understanding of cytomegalovirus infection in immunocompetent individuals. Journal of Dermatological Science.2000, 22 (3): 196.
6Trincado DE, Rawlinson WD. Congenital and perinatal infections with cytomegalovirus[ J ]. J Pediatr Child Health, 2001,37(2): 187- 192.
7Barrio VR, Darmstadt GL. Rash and opportunistic pneumonia in a malnourished infant adopted from China[J]. Clin Infect Dis, 2000,30(2) :408 - 409.
8Khare MD, Sharland M. Cytomegalovirus treatment options in immunocompromised patients[J ]. Expert Opin Pharmacother , 2001, 2(8): 1247 - 1257.
9Wang PS.Prevalance of antibodies to Epstein BarrVirus and cytomegalovirus in sera from a group of children in the Peoples Reoublic of China.J Infect Dis,1986,153; 150
10Avala E, Greene J, Sandin R, et al.Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation[J].Bone Marrow Transplantation, 2006, 37(9): 851- 856.
